|

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2026-07-13
Est. completion2028-07
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07604220

Summary

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria

* Adults ≥18 years.
* Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
* Undergoing FDG-PET as part of standard care.
* Ability to provide informed consent.

Exclusion Criteria

• Inability to provide informed consent.

Conditions5

Cardiac SarcoidosisHeart DiseaseSarcoidosis With MyocarditisSarcoidosis of the HeartSarcoidosis, Cardiac

Locations1 site

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Anna Pick507-255-0630pick.anna@mayo.edu

Find trials near these locations

All trials in Minnesota

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.